 |
|
| Venture Capital Alphabetical (page 1 of 240) |
|
-123-
Offices: London, England
3i is a world leader in venture capital and private equity. At 3i it's the
effort they put into understanding people, as well as business, that has
made them a leading force in venture capital today. Since its foundation
in 1945, 3i has invested in more than 14,000 companies in a wide range of
sectors from start-ups to late stage transactions, focusing on businesses
with high growth potential and strong management. They have over 300 investment
professionals, 18 industry advisers, many with over 20 years experience
in their sector.
Offices: Budapest, Hungary; Prague, Czech Republic & Warszawa, Poland
3TS Venture Partners is the exclusive advisor to the Technologieholding
Central and Eastern European Funds. It is owned jointly by the management
team and 3i Group Plc and SITRA, the Finnish National Agency for Research
and Development. 3TS Venture Partner's role is to identify, evaluate and
recommend investments. After investments are closed, 3TS represents the
Funds either directly and/or with non-executive directors with positions
of the Board and works with the management to fully support the operational
development of the business.
Offices: Saratoga, California & Singapore
3V SourceOne Capital is a next generation venture capital partnership based
in Silicon Valley and Singapore specializing in investments in emerging
companies developing cutting-edge enabling technologies in the communications,
IT and the life sciences sectors. The partners formerly managed the US and
China portfolios of venture funds totaling US$125 million. They also led
the organization of a technology fund anchored by reputable financial institutions
in the US, Singapore and Taiwan.
Offices: Menlo Park, California & Waltham, Massachusetts
5AM Ventures is a $65 million seed and early-stage fund that is focused
on creating and building the next generation of leading biotechnology companies.
5AM works with entrepreneurs and scientists to help shape the strategic
mission of new start-ups (or spin-outs) and provides business, financial,
deal structuring, recruiting and other assistance in the company-building
process. 5AM provides the initial stages of capital, either alone or in
a VC syndicate, bringing companies to critical value-creating milestones
which enable subsequent financings with established VC firms.
Offices: Edina, Minnesota
7 Health Ventures is a professional venture capital fund dedicated to
investing in Israeli and Israeli-related companies, developing
healthcare technologies and products. Their commitment to their
entrepreneurs is for a long-term partnership because they understand
that building a successful company takes time. They accompany their
entrepreneurs with integrity, resourcefulness and dedication. Their goal
is to bring their ideas to life by helping them turn their vision into
breakthrough technologies and robust products.
Offices: Auburndale, Massachusetts
At 20/20, they have assembled a group of experts with a diverse range of
backgrounds who have developed a vision for healthcare in the year 2020.
This vision guides their strategy for developing and commercializing technologies
that they feel will accelerate the implementation of successful 'Personalized
Medicine' approaches. Their team approach relies on an efficient and strategic
use of time and resources, to bring their portfolio companies' products
to market.
Offices: Luxembourg, Germany; Milan, Italy & Paris France
360 Capital Partners is a venture capital firm, investing in innovation
at full scale, in Europe and more particularly in France and Italy. The
new 360 Capital fund, a Luxembourg based Sicar, has reached a total
capital commitment of over €100m. 360 Capital Partners is managed by a
consolidated team which has cumulated 50+ years of venture capital
experience in investing in, following-up and/or exiting from over 60
companies and which have more than €200 million under management,
provided by top tier international investors.
Offices: Boston, Massachusetts
.406 Ventures is an early-stage venture capital firm that invests in innovative
information technology and services companies founded by the finest entrepreneurs.
They are a veteran team of industry entrepreneurs, operators and investors
who apply real world experience, deep industry knowledge and networks, and
strong company-building skills to create value for their entrepreneurs and
investing partners. .406 typically is the lead, first institutional investor
in early-stage and de novo investments.
Print
(page 2)
Resources
to
top